Jimini Health

The company's platform is designed for large behavioral health provider organizations, enabling them to deploy patient-facing AI in a safe, compliant, and scalable manner. Jimini Health's core service integrates teletherapy sessions with licensed clinicians and continuous support from Sage, which assists with patient intake, personalized activities, and messaging between appointments. This model ensures that clinicians remain in control of all care decisions, with every patient-AI interaction visible to the supervising therapist. Sage operates based on the specific treatment plan created by the human clinician and does not improvise, ensuring a structured and clinically validated approach.

Initially, Jimini Health focused on selling directly to patients, treating adults with low to moderate mental health needs, including anxiety, depression, OCD, and PTSD. The business model is shifting towards contracting with businesses and partnering with large clinical organizations. The service is available via insurance, as a workplace health benefit, or through direct cash payments, with sessions starting at $200. The company has raised over $25 million in total funding, including an $8 million pre-seed round in November 2024 and a $17 million seed round in March 2026. Investors include Zetta Venture Partners, LionBird, M13, and Town Hall Ventures. The firm is leveraging this capital to expand its partnerships with provider organizations and further develop its AI capabilities.